Long-term echographic follow-up of children infected with Schistosoma haematobium after treatment with praziquantel;Suivi échographique prolongé d'enfants infestés par Schistosoma haematobium après traitement par praziquantel

Tropical Medicine and International Health

Volumn 6, Issue 1, 2001, Pages 24-30

  Campagne, G ^a,c   Garba, A ^c   Barkire H ^a   Vera, C ^b   Sidiki, A ^a  

^a Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^b Programme de Lutte Contre la Bilharziose Urinaire Dans la Vallée du Fleuve Niger PLBU   (Nigeria)

^c CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

CHILD HEALTH; DRUG PRESCRIBING; HEALTH CARE; SCHISTOSOMIASIS;

ADOLESCENT; ARTICLE; BLADDER DISEASE; CHILD; DISEASE SEVERITY; ECHOGRAPHY; ENDEMIC DISEASE; HEALTH SURVEY; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PARASITE IDENTIFICATION; PREVALENCE; REINFECTION; RETREATMENT; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SCHOOL CHILD; URINARY TRACT DISEASE;

ADOLESCENT; ANTHELMINTICS; CHILD; DATA COLLECTION; FEMALE; HEMATURIA; HUMANS; MALE; NIGER; PRAZIQUANTEL; PREVALENCE; RECURRENCE; SCHISTOSOMIASIS HAEMATOBIA; URINARY TRACT;

NIGER;

PROTOZOA; SCHISTOSOMA HAEMATOBIUM;

EID: 17144453684     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.00660.x     Document Type: Article

References (12)

1. Contrôle de qualité lors de l'évaluation échographique de la morbidité due à Schistosoma haematobium au Niger
2. Evaluation préliminaire des indicateurs indirects de morbidité au cours du programme de lutte contre la bilharziose urinaire dans la valiée du fleuve Niger
3. Predicting the impact of school-based treatment for urinary schistosomiasis given by the Ghana Parternship for Child Development
4. Schistosim: A microsimulation model for the epidemiology and control of schistosomiasis
5. Ultrasonic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel
6. Reversibility of urinary tract abormalities due to Schistosoma haematobium infection
7. Reduction of pathological findings in urine and bladder lesions in infection with Schistosoma haematobium after treatment with Praziquantel
8. A longitudinal study of endemic urinary Schistosomiasis in a small East African Community
9. Ultrasound scanning for detecting morbidity due to Schistosoma haematobium and its resolution following treatment with different doses of praziquantel
10. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania
11. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection